Mesotherapy with Bicalutamide: A New Treatment for Androgenetic Alopecia

Bicalutamide is a selective androgen receptor antagonist. To date, it has been used orally with good efficacy results, but not in mesotherapy. In our center, we assessed whether patients undergoing bicalutamide mesotherapy showed positive responses and tolerated the local administration of bicalutam...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomez-Zubiaur, Alba, Andres-Lencina, Juan Jose, Cabezas, Víctor, Corredera, Cristina, di Brisco, Fabio, Ferrer, Blanca, Rodriguez-Villa, Ana, Subiabre-Ferrer, Daniela, Valenzuela, Cristian, Diez, David Vega, Ricart, Jose Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251290/
https://www.ncbi.nlm.nih.gov/pubmed/37305191
http://dx.doi.org/10.4103/ijt.ijt_78_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251290/
https://www.ncbi.nlm.nih.gov/pubmed/37305191
http://dx.doi.org/10.4103/ijt.ijt_78_21

Ejemplares similares